First Patient Dosed in Phase II Basket Trial of Taletrectinib for Solid Tumors with NTRK Fusion

NEXT STORY
atai Life Sciences Announces Pricing of Upsized Initial Public Offering
PREV STORY
HUTCHMED Launches Hong Kong Initial Public Offering
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Surgical Care Affiliates Partners With The Surgery Center at Doral

DEERFIELD, Ill., Dec. 12, 2016 (GLOBE NEWSWIRE) -- Surgical Care Affiliates, Inc. (NASDAQ:SCAI) (“SCA”), ...

author_avatar
NASDAQ Market News

Ritter Pharmaceuticals Announces Issuance of New Patents for its Lactose Intolerance Treatment, RP-G28, and Provides an Update on its Path Forward into Phase 3

LOS ANGELES, May 02, 2017 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) (“Ritter Pharmaceuticals” ...

author_avatar
NASDAQ Market News

DBV Technologies Announces Results from Phase II Study of Viaskin Milk in Milk-Allergic Patients

Press ReleaseMontrouge, France, February 26, 2018                                                                                                                                                                           DBV Technologies Announces Results from Phase ...

author_avatar
NASDAQ Market News